摘要
【目的】研究血红素氧合酶-1(HO-1)和线粒体ATP敏感性钾(Mitochondrial KATP,mitoKATP)通道与吗啡预处理的延迟性心肌保护作用的关系。【方法】雄性Wistar大鼠随机分为5组。IR组(A组),腹腔注射生理盐水5mL,24h后行心肌缺血再灌注(IR);Mor组(B组),腹腔注射吗啡3mg/kg(用生理盐水稀释至5mL),24h后行心肌IR;HO-1阻滞剂(ZnPP—IX)+Mor组(C组),腹腔注射ZnPP—IX 20μg/kg,30min后腹腔注射吗啡3mg/kg,24h后行心肌IR;mitoKATP通道阻滞剂(5-HD)+Mor组(D组),腹腔注射5-HD5mg/kg,20min后腹腔注射吗啡3mg/kg,24h后行心肌IR;Mor+5-HD组(E组),腹腔注射吗啡3mg/kg,24h后行IR,但在缺血前10min腹腔注射5-HD5mg/kg。各组于缺血前、缺血25min、再灌注30、60、120min记录大鼠心率(HR)、平均动脉压(MAP)。心肌缺血再灌注结束即刻采用EB/TTC双重染色,称重法测定心肌梗死面积,比较各组心肌梗死面积发生情况。【结果】和A组相比,B组心肌梗死面积明显减小,且差异有显著性(P〈0.05);C组、D组和E组心肌梗死面积无明显差异(P〉0.05)。【结论】HO-1和mitoKATP通道参与了吗啡预处理的延迟性心肌保护作用;mitoKATP通道既是启动因子又是效应器。
[Objective] To explore whether heine oxygenase-1 (HO-1) and mitochondrial ATP sensitive potassium (mitOKATe) channel are involved in morphine-induced delayed cardioprotection. [Methods] Wistar rats were randomly divided into 5 groups. And 25 rain regional ischemia plus 2 h reperfusion (IR) at 24 h post treatment of 0.9% sodium chloride 5 mL in group IR; morphine 3mg/kg in group Mor; HO-linhibitor ZnPP-IX 20μg/kg plus morphine 3 mg/kg in group ZnPP4-Mor; mitOKATe channel antagonist 5-hydroxydecanoic acid (5-HD) 5 mg/kg plus morphine 3 mg/kg in group 5-HD+Mor. In group Mor+5-HD, IR 24 h after morphine 3mg/kg and 10 rain after 5-HD 5 mg/kg. Heart rate (HR) and mean arterial blood pressure (MAP) were recorded at pre-ischemia, 30, 60, 120 rain post-reperfusion. Infarct size (percentage area at risk) was assessed at the end of reperfusion. [Results] No statistical differences in HR or MAP existed among five groups. Infarct size was 60.0% ± 10.5 % in group IR. Pretreatment with morphine reduced infarct size to 27.4%±8.2% after 24 h in group Mor. The reduction of infarct size by morphine was abolished by 5-HD given either before morphine application or before ischemia. And cardioprotection was abolished by ZnPP-IX given before morphine in group ZnPP+Mor . [Conclusion] Both HO-1 and mitoKATP are probably involved in delayed cardioprotection evoked by morphine. And mitOKATp channel may serve as both a trigger and a effeetor in cardioproteetion.
出处
《医学临床研究》
CAS
2015年第7期1373-1375,共3页
Journal of Clinical Research